BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 18367578)

  • 1. Comparison of the Third Wave Invader human papillomavirus (HPV) assay and the digene HPV hybrid capture 2 assay for detection of high-risk HPV DNA.
    Ginocchio CC; Barth D; Zhang F
    J Clin Microbiol; 2008 May; 46(5):1641-6. PubMed ID: 18367578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative review of laboratory-developed tests utilizing Invader HPV analyte-specific reagents for the detection of high-risk human papillomavirus.
    Stillman MJ; Day SP; Schutzbank TE
    J Clin Virol; 2009 Jul; 45 Suppl 1():S73-7. PubMed ID: 19651372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An HPV 16, 18, and 45 genotyping test based on Hybrid Capture technology.
    Thai H; Rangwala S; Gay T; Keating K; McLeod S; Nazarenko I; O'Neil D; Pfister D; Loeffert D
    J Clin Virol; 2009 Jul; 45 Suppl 1():S93-7. PubMed ID: 19651375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The next-generation Hybrid Capture High-Risk HPV DNA assay on a fully automated platform.
    Eder PS; Lou J; Huff J; Macioszek J
    J Clin Virol; 2009 Jul; 45 Suppl 1():S85-92. PubMed ID: 19651374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the PapilloCheck® assay with the digene HC2 HPV DNA assay for the detection of 13 high-risk human papillomaviruses in cervical and anal scrapes.
    Didelot MN; Boulle N; Damay A; Costes V; Segondy M
    J Med Virol; 2011 Aug; 83(8):1377-82. PubMed ID: 21678441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus.
    Dalstein V; Merlin S; Bali C; Saunier M; Dachez R; Ronsin C
    J Virol Methods; 2009 Mar; 156(1-2):77-83. PubMed ID: 19041893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of the Roche Cobas HPV Test With the Hybrid Capture 2 Test for the Detection of High-Risk Human Papillomavirus Genotypes.
    Levi AW; Bernstein JI; Hui P; Duch K; Schofield K; Chhieng DC
    Arch Pathol Lab Med; 2016 Feb; 140(2):153-7. PubMed ID: 26910220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of fluorescence in situ hybridization, hybrid capture 2 and polymerase chain reaction for the detection of high-risk human papillomavirus in cervical cytology specimens.
    Voss JS; Kipp BR; Campion MB; Sokolova IA; Henry MR; Halling KC; Clayton AC
    Anal Quant Cytol Histol; 2009 Aug; 31(4):208-16. PubMed ID: 19736868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical performance of Invader technology and SurePath when detecting the presence of high-risk HPV cervical infection.
    Harvey M; Stout S; Starkey CR; Hendren R; Holt S; Miller GC
    J Clin Virol; 2009 Jul; 45 Suppl 1():S79-83. PubMed ID: 19651373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human papillomavirus detection and genotyping, by HC2, full-spectrum HPV and molecular beacon real-time HPV assay in an Irish colposcopy clinic.
    Keegan H; Pilkington L; McInerney J; Jeney C; Benczik M; Cleary S; von Bunau G; Turner M; D'Arcy T; O' Toole S; Pal-Szenthe B; Kaltenecker B; Mózes J; Kovács A; Solt A; Bolger N; O'Leary J; Martin C
    J Virol Methods; 2014 Jun; 201():93-100. PubMed ID: 24583109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hybrid capture 2 High-Risk HPV results in the low positive range with cobas® HPV Test results from the ATHENA study.
    Rao A; Sandri MT; Sideri M; Young S; Sharma A; Behrens C
    J Clin Virol; 2013 Sep; 58(1):161-7. PubMed ID: 23895930
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Anyplex II HPV28 assay with the Hybrid Capture 2 assay for the detection of HPV infection.
    Kwon MJ; Roh KH; Park H; Woo HY
    J Clin Virol; 2014 Apr; 59(4):246-9. PubMed ID: 24568964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The concordance of HPV DNA detection by Hybrid Capture 2 and careHPV on clinician- and self-collected specimens.
    Chen W; Jeronimo J; Zhao FH; Qiao YL; Valdez M; Zhang X; Kang LN; Bansil P; Paul P; Bai P; Peck R; Li J; Chen F; Stoler MH; Castle PE
    J Clin Virol; 2014 Dec; 61(4):553-7. PubMed ID: 25453572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus genotype specificity of hybrid capture 2.
    Castle PE; Solomon D; Wheeler CM; Gravitt PE; Wacholder S; Schiffman M
    J Clin Microbiol; 2008 Aug; 46(8):2595-604. PubMed ID: 18579716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical laboratory evaluation of Invader® chemistry and hybrid capture for detection of high-risk human papillomavirus in liquid-based cytology specimens.
    Munson E; Du Chateau BK; Bellerose B; Czarnecka J; Griep J
    Diagn Microbiol Infect Dis; 2011 Nov; 71(3):230-5. PubMed ID: 21899977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of analytical and clinical performances of the digene HC2 HPV DNA assay and the INNO-LiPA HPV genotyping assay for detecting high-risk HPV infection and cervical neoplasia among HIV-positive African women.
    Ngou J; Gilham C; Omar T; Goumbri-Lompo O; Doutre S; Michelow P; Kelly H; Didelot MN; Chikandiwa A; Sawadogo B; Delany-Moretlwe S; Meda N; Costes V; Mayaud P; Segondy M
    J Acquir Immune Defic Syndr; 2015 Feb; 68(2):162-8. PubMed ID: 25394189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition from Hybrid Capture 2 to Cobas 4800 in Hpv detection: sensitivity and specificity for Cin2+ in two time periods.
    Bottari F; Boveri S; Iacobone AD; Gulmini C; Igidbashian S; Cassatella MC; Landoni F; Sandri MT
    Infect Dis (Lond); 2018 Jul; 50(7):554-559. PubMed ID: 29463149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High performance of a new PCR-based urine assay for HPV-DNA detection and genotyping.
    Tanzi E; Bianchi S; Fasolo MM; Frati ER; Mazza F; Martinelli M; Colzani D; Beretta R; Zappa A; Orlando G
    J Med Virol; 2013 Jan; 85(1):91-8. PubMed ID: 23097252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency of the APTIMA HPV Assay for detection of HPV RNA and DNA targets.
    Getman D; Aiyer A; Dockter J; Giachetti C; Zhang F; Ginocchio CC
    J Clin Virol; 2009 Jul; 45 Suppl 1():S49-54. PubMed ID: 19651369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens.
    Iftner T; Wang L; Iftner A; Holz B; Haedicke-Jarboui J; Iftner N; von Wasielewski R; Martus P; Boehmer G
    BMC Infect Dis; 2016 Nov; 16(1):672. PubMed ID: 27835974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.